Coronavirus in China: 2021 outlook brightens for health care operators, pharmaceutical and device makers after price cuts

Chinese health care stocks rallied 61 per cent last year with more upside expected in 2021. The pressure, however, will be on drug makers and device manufacturers after massive price cuts.
( read original story …)